Hennion & Walsh Asset Management Inc. Lowers Stock Position in Axon Enterprise, Inc $AXON

Posted by Brian Himes on Aug 10th, 2026

Hennion & Walsh Asset Management Inc. lessened its stake in Axon Enterprise, Inc (NASDAQ:AXON – Free Report) by 11.1% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,866 shares of the biotechnology company’s stock after selling 1,230 shares during the period. Hennion & Walsh Asset Management Inc.’s holdings in Axon Enterprise were worth $5,531,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently made changes to their positions in AXON. Creative Financial Designs Inc. ADV purchased a new position in Axon Enterprise in the fourth quarter worth $28,000. Sound Income Strategies LLC raised its position in Axon Enterprise by 550.0% during the fourth quarter. Sound Income Strategies LLC now owns 52 shares of the biotechnology company’s stock valued at $30,000 after purchasing an additional 44 shares in the last quarter. Camelot Portfolios LLC bought a new stake in Axon Enterprise during the fourth quarter worth about $30,000. AlphaCentric Advisors LLC bought a new stake in Axon Enterprise during the fourth quarter worth about $34,000. Finally, Darwin Wealth Management LLC purchased a new position in shares of Axon Enterprise in the 2nd quarter worth about $37,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Insider Activity at Axon Enterprise

In other Axon Enterprise news, CEO Patrick W. Smith sold 10,000 shares of the business’s stock in a transaction dated Tuesday, July 7th. The shares were sold at an average price of $643.79, for a total value of $6,437,900.00. Following the transaction, the chief executive officer owned 3,040,997 shares in the company, valued at approximately $1,957,763,458.63. The trade was a 0.33% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CRO Cameron Brooks sold 1,242 shares of the business’s stock in a transaction dated Thursday, June 4th. The shares were sold at an average price of $500.00, for a total transaction of $621,000.00. Following the completion of the transaction, the executive owned 49,710 shares in the company, valued at $24,855,000. The trade was a 2.44% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 58,989 shares of company stock worth $30,527,983 over the last ninety days. Insiders own 4.20% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on AXON shares. Morgan Stanley increased their price objective on Axon Enterprise from $600.00 to $640.00 and gave the company an “overweight” rating in a research report on Thursday. JPMorgan Chase & Co. upped their target price on Axon Enterprise from $750.00 to $755.00 and gave the stock an “overweight” rating in a research note on Thursday, May 7th. Piper Sandler increased their price target on shares of Axon Enterprise from $724.00 to $732.00 and gave the company an “overweight” rating in a research report on Thursday. Weiss Ratings reissued a “hold (c-)” rating on shares of Axon Enterprise in a research note on Wednesday. Finally, UBS Group boosted their price objective on shares of Axon Enterprise from $440.00 to $600.00 and gave the stock a “neutral” rating in a report on Thursday. Thirteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $730.92.

Check Out Our Latest Analysis on Axon Enterprise

Axon Enterprise Price Performance

Shares of Axon Enterprise stock opened at $571.01 on Monday. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.15 and a quick ratio of 1.80. Axon Enterprise, Inc has a one year low of $339.01 and a one year high of $878.62. The business’s 50 day simple moving average is $513.80 and its two-hundred day simple moving average is $473.45. The stock has a market capitalization of $46.39 billion, a P/E ratio of 236.93, a price-to-earnings-growth ratio of 11.65 and a beta of 1.39.

Axon Enterprise (NASDAQ:AXON – Get Free Report) last released its quarterly earnings data on Tuesday, August 4th. The biotechnology company reported $1.88 earnings per share for the quarter, beating analysts’ consensus estimates of $1.84 by $0.04. Axon Enterprise had a return on equity of 2.84% and a net margin of 6.19%.The firm had revenue of $904.39 million during the quarter, compared to analyst estimates of $876.42 million. During the same quarter in the prior year, the firm posted $2.12 earnings per share. The business’s quarterly revenue was up 35.3% compared to the same quarter last year. Analysts forecast that Axon Enterprise, Inc will post 1.63 EPS for the current year.

Key Stories Impacting Axon Enterprise

Here are the key news stories impacting Axon Enterprise this week:

Positive Sentiment: Strong Q2 growth and higher outlook: Axon reported second-quarter revenue of approximately $904 million, up 35% year over year and above analyst expectations. The company raised its 2026 revenue-growth forecast to 32%–34%, citing record bookings, international expansion and demand for its connected devices and software. Axon Beat Estimates and Raised Guidance, Shares Dropped
Positive Sentiment: AI and Dedrone momentum: AI Era revenue, including Draft One automated police-report software, grew nearly 700% from a year earlier. Dedrone counter-drone revenue exceeded $100 million, supported by deployments at all 11 World Cup sites, strengthening Axon’s long-term growth narrative. Axon Stock Falls After AI, Drone Wins Fuel Q2 Earnings Beat
Positive Sentiment: Analyst and retail support: UBS raised its price target to $600 while maintaining a Neutral rating, and retail traders showed interest in buying the post-earnings pullback. William Blair also reiterated a Buy rating, highlighting recurring-revenue growth, counter-drone demand and Axon’s expanding AI platform. UBS Raises Axon Price Target
Neutral Sentiment: Valuation remains elevated: Axon’s rapid share-price recovery has increased scrutiny of its valuation. Some analysis considers the stock expensive on discounted cash flow and only fairly valued on sales multiples, potentially limiting further gains unless growth remains strong. Axon Stock Could Be Overvalued
Negative Sentiment: Margins and cash flow pressured the initial reaction: Software gross margin declined to 71.3% from 75.6%, while a greater mix of professional services, memory costs and investments in new products reduced profitability. Free cash flow also turned negative, and quarterly EPS was reported as slightly below some consensus estimates, prompting an initial post-earnings selloff. Axon Posts Lower Quarterly Gross Margin

About Axon Enterprise

(Free Report)

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.